Xiaofeng Ding
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in
-
- Ubiquitin and proteasome pathways 6
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- Genomics and Chromatin Dynamics 4
- RNA Interference and Gene Delivery 3
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Shuanglin Xiang (18 shared papers)Xiang Hu (16 shared papers)Jianlin Zhou (9 shared papers)Chang Zhou (8 shared papers)Xing Zhang (6 shared papers)Xin Yang (5 shared papers)Yan Luo (5 shared papers)Meilian Liu (5 shared papers)
- Journals
- Cell Death and Disease (3 papers)Theranostics (2 papers)PLoS ONE (2 papers)Journal of Cellular Biochemistry (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Xiaofeng Ding
40 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 260
- Molecular Biology 499
- Immunology 131
- Drug Discovery 1
- Physiology 129
Countries citing papers authored by Xiaofeng Ding
This map shows the geographic impact of Xiaofeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Ding more than expected).
Fields of papers citing papers by Xiaofeng Ding
This network shows the impact of papers produced by Xiaofeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Ding. The network helps show where Xiaofeng Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 95 | |
| 2 | 2016 | 79 | |
| 3 | 2011 | 76 | |
| 4 | 2018 | 56 | |
| 5 | 2008 | 52 | |
| 6 | 2020 | 46 | |
| 7 | 2019 | 41 | |
| 8 | 2021 | 40 | |
| 9 | 2014 | 37 | |
| 10 | 2019 | 36 | |
| 11 | 2020 | 34 | |
| 12 | 2013 | 31 | |
| 13 | 2016 | 28 | |
| 14 | 2014 | 27 | |
| 15 | 2013 | 27 | |
| 16 | 2018 | 27 | |
| 17 | 2023 | 24 | |
| 18 | 2009 | 24 | |
| 19 | 2013 | 23 | |
| 20 | 2019 | 23 |
About Xiaofeng Ding
Xiaofeng Ding is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Cell Biology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (4 papers), Genomics and Chromatin Dynamics (4 papers), RNA Interference and Gene Delivery (3 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Cancer Research (260 citations), Molecular Biology (499 citations), Immunology (131 citations), Drug Discovery (1 citation) and Physiology (129 citations). Xiaofeng Ding has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Shuanglin Xiang, Xiang Hu, Jianlin Zhou, Chang Zhou, Xing Zhang, Xin Yang, Yan Luo, Meilian Liu, Yuzhong Xiao and Xuexian O. Yang. Their work appears in journals such as Cell Death and Disease, Theranostics, PLoS ONE, Journal of Cellular Biochemistry and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.